VTP50469 mesylate
Product Specifications
CAS Number
2169919-27-9
Target
Apoptosis|||Epigenetic Reader Domain|||Others
Related Pathways
Chromatin/Epigenetic|||Apoptosis|||Others
Bioactivity
VTP-50469 is a novel, potent, selective, orally-available MeninMLL1 inhibitor, being effectively against MLL-rearranged and NPM1c+ leukemia, selectively killing cell lines with MLLrearrangements and NPM1c+ mutations.
Smiles
CS(O)(=O)=O.CS(O)(=O)=O.CC(C)N(C(C)C)C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(C1)CCN(C[C@H]1CC[C@@H](CC1)NS(C)(=O)=O)CC2
Molecular Formula
C33H51FN6O7S2
Molecular Weight
726.9244
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/404E19AD-D466-426D-9F40-7755290BEFC8/T69846
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Monoclonal CD4 Antibody (CE9.1 (Clenoliximab)) [CoraFluor 1]](https://cdn.genprice.uk/genprice/genprice2.png)
NBP2-52681CL1 0.1 mL
Rabbit Monoclonal CD4 Antibody (CE9.1 (Clenoliximab)) [CoraFluor 1]
Ask
View Details 
GTR15240591 1 Vial
Lentiviral mouse Id2 shRNA (UAS) - Lentiviral mouse Id2 shRNA (UAS, iRFP) (100)
Ask
View Details PA1449-FITC 100 µg/Vial
Anti-D-dopachrome decarboxylase DDT Antibody Picoband®, FITC Conjugate
Ask
View Details